Time-frequency analysis of the surface electrocardiogram in atrial fibrillation for monitoring and predicting antiarrhythmic drug effects

This study explored the potential clinical value of Time-Frequency Analysis (TFA) of the sulface ECG for monitoring and predicting atrial drug action in atrial fibrillation (AF). Baseline fwo-minute ECG recordings were made in 42 patients with persisient AF and after oral Jecainide (n=24) or amiodarone (n=18) initiation. Afrer spariotemporal QRXT cancellation, TFA was perjbrmed and ( I ) mean fibrillatory rate, (2) rate stability, and (3) exponential decay of fundamental and harmonic frequency components were determined. Patienrs in whom AF terminated (n=I2) had a lower atrial rate and a smaller exponential decay at baseline than patients who remained in AF. In the remaining 30 patients, drug loading organized AF as expressed by ( 1 ) decrease of atrial rate, (2) increase of ECG segments with stable AF, and (3) decrease of exponentid decay. In conclusion, TFA has the potential to predict and monitor individual antiarrhythmic drug responses in AF.

[1]  Leif Sörnmo,et al.  Sequential characterization of atrial tachyarrhythmias based on ECG time-frequency analysis , 2004, IEEE Transactions on Biomedical Engineering.

[2]  M. Allessie,et al.  Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol. , 2000, Circulation.

[3]  Leif Sörnmo,et al.  Characterization of atrial fibrillation using the surface ECG: time-dependent spectral properties , 2001, IEEE Transactions on Biomedical Engineering.

[4]  D. Haines,et al.  Assessment of Global Atrial Fibrillation Organization to Optimize Timing of Atrial Defibrillation , 2001, Circulation.

[5]  Martin Stridh,et al.  Frequency Measures Obtained from the Surface Electrocardiogram in Atrial Fibrillation Research and Clinical Decision‐Making , 2003, Journal of cardiovascular electrophysiology.

[6]  M. Allessie,et al.  High-density mapping of electrically induced atrial fibrillation in humans. , 1994, Circulation.

[7]  A. Bollmann,et al.  Analysis of the Surface Electrocardiogram for Monitoring and Predicting Antiarrhythmic Drug Effects in Atrial Fibrillation , 2004, Cardiovascular Drugs and Therapy.

[8]  D. Todd,et al.  Effect of Amiodarone on Dispersion of Atrial Refractoriness and Cycle Length in Patients with Atrial Fibrillation , 2003, Journal of cardiovascular electrophysiology.

[9]  Marek Malik,et al.  Optimum lead positioning for recording bipolar atrial electrocardiograms during sinus rhythm and atrial fibrillation , 1998, Clinical cardiology.